Fahed Al-Marzooqi

CIK: 0001928247

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

VTVT

vTv Therapeutics Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (2 total)

VTVT
vTv Therapeutics Inc.
Jun 26, 2026
Award(A)
Director stock option (right to buy)
Direct
6K shares at avg. $35.08-
VTVT
vTv Therapeutics Inc.
Jun 10, 2025
Award(A)
Director stock option (right to buy)
Direct
4K shares at avg. $16.59-

		Type	Shares	Price		Ownership
Jun 26, 2026	VTVT vTv Therapeutics Inc.	Award(A) Director stock option (right to buy)	6,000	$35.08	-	Direct
Jun 10, 2025	VTVT vTv Therapeutics Inc.	Award(A) Director stock option (right to buy)	4,000	$16.59	-	Direct

1-2 of 2 transactions

About Al-Marzooqi Fahed

Al-Marzooqi Fahed (SEC CIK 0001928247) files insider reports with the SEC as Director of vTv Therapeutics Inc. (VTVT).

Signal8 holds 2 ownership filings by Al-Marzooqi Fahed, all Form 4s, filed between Jun 12, 2025 and Jun 29, 2026. Those filings report 2 transactions, from Jun 10, 2025 to Jun 26, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Al-Marzooqi Fahed's filings is in HIGH POINT, NC.

Recent filings by Al-Marzooqi Fahed

Jun 26, 2026: Grant or award of VTVT derivative securities (Form 4, code A).
Jun 10, 2025: Grant or award of VTVT derivative securities (Form 4, code A).

Other insiders filing for vTv Therapeutics Inc. (VTVT)

BAKER BROS. ADVISORS LP, Director
SPIEGELMAN DANIEL K, Director
AKKARAJU SRINIVAS, Director
Phillips Anne M., Director
Tung Michael Stephen, EVP & CFO
SEKHRI PAUL J, Pres, CEO and Exec Chairperson

How to read Form 4 transaction codes